SEC Form 4/A · accession 0001209191-16-157109
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Daniel L Kisner
Director
Period of report
Feb 19, 2014
Accepted (ET)
Dec 30, 2016 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 19, 2014 | J | 3,145 | $0.00 | A | 3,145 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro rata distribution of 2,137 shares from Aberdare Partners III, L.P., of which the Reporting Person is a limited partner, and a pro rata distribution of 1,008 shares from Aberdare GP III, L.L.C., of which the Reporting Person is a non-managing member.
- F2Held by family trust of which the Reporting Person is a trustee.
Remarks
This Form 4/A amends the Form 4 filing made on behalf of the Reporting Person on February 25, 2014. The Form 4, as originally filed, incorrectly reported the ownership form as direct in Table I, Column 6. The amount of securities beneficially owned in Table I, Column 5 in the Form 4 filing made on behalf of the Reporting Person on April 10, 2015 incorrectly included the 3,145 shares of common stock acquired on February 19, 2014 as held in direct ownership form.